Table of Contents

1 Study Coverage

• 1.1 Thrombectomy Devices Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Thrombectomy Devices Market Size Growth Rate by Product
  • 1.4.2 Automated
  • 1.4.3 Manual
• 1.5 Market by End User
  • 1.5.1 Global Thrombectomy Devices Market Size Growth Rate by End User
  • 1.5.2 Peripheral
  • 1.5.3 Coronary
  • 1.5.4 Neural
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Thrombectomy Devices Market Size
  • 2.1.1 Global Thrombectomy Devices Revenue 2014-2025
  • 2.1.2 Global Thrombectomy Devices Sales 2014-2025
• 2.2 Thrombectomy Devices Growth Rate by Regions
  • 2.2.1 Global Thrombectomy Devices Sales by Regions
  • 2.2.2 Global Thrombectomy Devices Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Thrombectomy Devices Sales by Manufacturers
  • 3.1.1 Thrombectomy Devices Sales by Manufacturers
  • 3.1.2 Thrombectomy Devices Sales Market Share by Manufacturers
  • 3.1.3 Global Thrombectomy Devices Market Concentration Ratio (CR5 and HHI)
• 3.2 Thrombectomy Devices Revenue by Manufacturers
  • 3.2.1 Thrombectomy Devices Revenue by Manufacturers (2014-2019)
  • 3.2.2 Thrombectomy Devices Revenue Share by Manufacturers (2014-2019)
• 3.3 Thrombectomy Devices Price by Manufacturers
• 3.4 Thrombectomy Devices Manufacturing Base Distribution, Product Types
  • 3.4.1 Thrombectomy Devices Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Thrombectomy Devices Product Type
  • 3.4.3 Date of International Manufacturers Enter into Thrombectomy Devices Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Thrombectomy Devices Sales by Product
• 4.2 Global Thrombectomy Devices Revenue by Product
• 4.3 Thrombectomy Devices Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Thrombectomy Devices Breakdown Data by End User

6 North America

• 6.1 North America Thrombectomy Devices by Countries
  • 6.1.1 North America Thrombectomy Devices Sales by Countries
  • 6.1.2 North America Thrombectomy Devices Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Thrombectomy Devices by Product
• 6.3 North America Thrombectomy Devices by End User

7 Europe

• 7.1 Europe Thrombectomy Devices by Countries
  • 7.1.1 Europe Thrombectomy Devices Sales by Countries
  • 7.1.2 Europe Thrombectomy Devices Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Thrombectomy Devices by Product
• 7.3 Europe Thrombectomy Devices by End User

8 Asia Pacific

• 8.1 Asia Pacific Thrombectomy Devices by Countries
  • 8.1.1 Asia Pacific Thrombectomy Devices Sales by Countries
  • 8.1.2 Asia Pacific Thrombectomy Devices Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Thrombectomy Devices by Product
• 8.3 Asia Pacific Thrombectomy Devices by End User

9 Central & South America

• 9.1 Central & South America Thrombectomy Devices by Countries
  • 9.1.1 Central & South America Thrombectomy Devices Sales by Countries
  • 9.1.2 Central & South America Thrombectomy Devices Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Thrombectomy Devices by Product
• 9.3 Central & South America Thrombectomy Devices by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Thrombectomy Devices by Countries
  • 10.1.1 Middle East and Africa Thrombectomy Devices Sales by Countries
  • 10.1.2 Middle East and Africa Thrombectomy Devices Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Thrombectomy Devices by Product
• 10.3 Middle East and Africa Thrombectomy Devices by End User

11 Company Profiles

• 11.1 Boston Scientific
  • 11.1.1 Boston Scientific Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Boston Scientific Thrombectomy Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Boston Scientific Thrombectomy Devices Products Offered
  • 11.1.5 Boston Scientific Recent Development
• 11.2 Medtronic
  • 11.2.1 Medtronic Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Medtronic Thrombectomy Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Medtronic Thrombectomy Devices Products Offered
  • 11.2.5 Medtronic Recent Development
• 11.3 Teleflex
  • 11.3.1 Teleflex Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Teleflex Thrombectomy Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Teleflex Thrombectomy Devices Products Offered
  • 11.3.5 Teleflex Recent Development
• 11.4 Penumbra
  • 11.4.1 Penumbra Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Penumbra Thrombectomy Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Penumbra Thrombectomy Devices Products Offered
  • 11.4.5 Penumbra Recent Development
• 11.5 The Spectranetics
  • 11.5.1 The Spectranetics Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 The Spectranetics Thrombectomy Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 The Spectranetics Thrombectomy Devices Products Offered
  • 11.5.5 The Spectranetics Recent Development
• 11.6 AngioDynamics
  • 11.6.1 AngioDynamics Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 AngioDynamics Thrombectomy Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 AngioDynamics Thrombectomy Devices Products Offered
  • 11.6.5 AngioDynamics Recent Development
• 11.7 Terumo
  • 11.7.1 Terumo Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Terumo Thrombectomy Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Terumo Thrombectomy Devices Products Offered
  • 11.7.5 Terumo Recent Development
• 11.8 Johnson and Johnson
  • 11.8.1 Johnson and Johnson Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Johnson and Johnson Thrombectomy Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Johnson and Johnson Thrombectomy Devices Products Offered
  • 11.8.5 Johnson and Johnson Recent Development
• 11.9 Stryker Corporation
  • 11.9.1 Stryker Corporation Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Stryker Corporation Thrombectomy Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Stryker Corporation Thrombectomy Devices Products Offered
  • 11.9.5 Stryker Corporation Recent Development
• 11.10 Vascular Solutions
  • 11.10.1 Vascular Solutions Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Vascular Solutions Thrombectomy Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Vascular Solutions Thrombectomy Devices Products Offered
  • 11.10.5 Vascular Solutions Recent Development

12 Future Forecast

• 12.1 Thrombectomy Devices Market Forecast by Regions
  • 12.1.1 Global Thrombectomy Devices Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Thrombectomy Devices Revenue Forecast by Regions 2019-2025
• 12.2 Thrombectomy Devices Market Forecast by Product
  • 12.2.1 Global Thrombectomy Devices Sales Forecast by Product 2019-2025
  • 12.2.2 Global Thrombectomy Devices Revenue Forecast by Product 2019-2025
• 12.3 Thrombectomy Devices Market Forecast by End User
• 12.4 North America Thrombectomy Devices Forecast
• 12.5 Europe Thrombectomy Devices Forecast
• 12.6 Asia Pacific Thrombectomy Devices Forecast
• 12.7 Central & South America Thrombectomy Devices Forecast
• 12.8 Middle East and Africa Thrombectomy Devices Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Thrombectomy Devices Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Thrombectomy devices are used to treat blood clots present in the arteries, veins, and capillaries.
The global Thrombectomy Devices market is valued at 1040 million US$ in 2018 and will reach 1600 million US$ by the end of 2025, growing at a CAGR of 5.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Thrombectomy Devices market based on company, product type, end user and key regions.

This report studies the global market size of Thrombectomy Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Thrombectomy Devices in these regions.
This research report categorizes the global Thrombectomy Devices market by top players/brands, region, type and end user. This report also studies the global Thrombectomy Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boston Scientific
Medtronic
Teleflex
Penumbra
The Spectranetics
AngioDynamics
Terumo
Johnson and Johnson
Stryker Corporation
Vascular Solutions

Market size by Product
Automated
Manual
Market size by End User
Peripheral
Coronary
Neural

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Thrombectomy Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Thrombectomy Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Thrombectomy Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Thrombectomy Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Thrombectomy Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Thrombectomy Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.